294 filings
Page 5 of 15
6-K
s0hzs99r igrtvor6xwx
16 Nov 21
Notice of 2021 Annual General Meeting and Explanatory Memorandum
6:14am
6-K
siaafy4k
15 Nov 21
US DoD Uniformed Services University Travelers’ Diarrhea Clinical Update
6:09am
6-K
itzng8u09hqdqvb5
9 Nov 21
US DoD Naval Medical Research Center Clinical Update
9:18pm
6-K
5uostjus9dfvezi31b
8 Oct 21
Report of Foreign Private Issuer
6:05am
6-K
1v7vvu
30 Sep 21
Annual report - 30 June 2021
11:42am
6-K
qbihgxw1yosl2tuaci6w
24 Sep 21
Report of Foreign Private Issuer
6:03am
6-K
wv9pbx oy
23 Sep 21
Immuron planned Acquisition of R&D Vaccine Company
7:13am
6-K
6yt6ihu3tj3ay4gupv
31 Aug 21
Appendix 4E Preliminary Final Report
7:15am
6-K
h9s3w5fnvjwnmx3j3f
7 Jul 21
Report of Foreign Private Issuer
7:48am
6-K
1yd3ch lh95
8 Jun 21
Report of Foreign Private Issuer
6:03am
6-K
oiptnz9v2ix4d0q
2 Jun 21
Report of Foreign Private Issuer
6:07am
6-K
4my69pj5mlc 23p
13 May 21
IMM124E – May offer a New modality for Inhibition of SARS-CoV-2
6:05am
6-K
je6v6ev7u5t q4rqlqr
25 Feb 21
Report of Foreign Private Issuer
7:57am
6-K
grx1md79lle03duj
11 Jan 21
Immuron to Participate in H.C. Wainwright & Co. BioConnect 2021 Virtual Conference
6:10am
6-K
htzcjojbe0 wtd
15 Dec 20
Immuron SARS-CoV-2 Research Agreement with Monash University
6:12am
6-K
cvm taxc16v2dbgfgp
25 Nov 20
Report of Foreign Private Issuer
6:05am
6-K
0lhuqkrkwnqvl
24 Nov 20
Immuron Receives AUD $358,280 R&D Tax Concession Refund
12:00am
6-K
k8c5s92z 2nbgxu
18 Nov 20
Report of Foreign Private Issuer
6:14am
6-K
zx33az 87uyzkt
17 Nov 20
Report of Foreign Private Issuer
8:24am